Beneficial Effect of Growth Hormone Treatment on Health-Related Quality of Life in Children with Prader-Willi Syndrome: A Randomized Controlled Trial and Longitudinal Study

Background/Aims: Growth hormone (GH) treatment is beneficial for children with Prader-Willi syndrome (PWS), but data about health-related quality of life (HRQOL) and effects of GH treatment are scarce. We, therefore, investigated the effects of GH treatment on HRQOL in PWS children. Methods: In a ra...

Full description

Saved in:
Bibliographic Details
Published in:Hormone research in paediatrics Vol. 84; no. 4; pp. 231 - 239
Main Authors: Bakker, Nienke E., Siemensma, Elbrich P.C., van Rijn, Marjon, Festen, Dederieke A.M., Hokken-Koelega, Anita C.S.
Format: Journal Article
Language:English
Published: Basel, Switzerland 01.01.2015
Subjects:
Adolescent
Body Composition - drug effects
Child
Female
Health Status
Hormone Replacement Therapy
Human Growth Hormone - pharmacology
Human Growth Hormone - therapeutic use
Humans
Longitudinal Studies
Male
Original Paper
Prader-Willi Syndrome - drug therapy
Prader-Willi Syndrome - psychology
Quality of Life
Surveys and Questionnaires
Treatment Outcome
Prader-Willi syndrome
Health-related quality of life
Growth hormone treatment
ISSN:1663-2818, 1663-2826, 1663-2826
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background/Aims: Growth hormone (GH) treatment is beneficial for children with Prader-Willi syndrome (PWS), but data about health-related quality of life (HRQOL) and effects of GH treatment are scarce. We, therefore, investigated the effects of GH treatment on HRQOL in PWS children. Methods: In a randomized controlled GH trial including 26 PWS children and during an 11-year longitudinal GH study in 76 children, we annually assessed HRQOL recorded by patients and parents, using a generic questionnaire (DUX25), containing 4 subdomains (Physical, Home, Social, and Emotional) and a PWS-specific questionnaire (DUXPW). Results: At baseline, PWS children rated HRQOL similar to or higher than healthy and obese children. GH-treated children reported an increase in HRQOL in the Physical and Social subdomains and the DUXPW compared to untreated children. Parents reported an increase in the Physical and Emotional subdomains and borderline in the total DUX25 compared to parents of untreated children. During the 11 years of GH treatment, the Physical subdomain continued to improve, according to parents, whereas the Home, Social and Emotional subdomains, the total DUX25, and the DUXPW remained similar, according to children and parents. Conclusions: PWS children rated HRQOL equally to or better than healthy and obese children. HRQOL increased during GH treatment, in contrast to HRQOL of untreated children. This effect was sustained during long-term GH treatment. PWS children consider themselves quite happy, despite some difficulties related to the syndrome.
AbstractList Background/Aims: Growth hormone (GH) treatment is beneficial for children with Prader-Willi syndrome (PWS), but data about health-related quality of life (HRQOL) and effects of GH treatment are scarce. We, therefore, investigated the effects of GH treatment on HRQOL in PWS children. Methods: In a randomized controlled GH trial including 26 PWS children and during an 11-year longitudinal GH study in 76 children, we annually assessed HRQOL recorded by patients and parents, using a generic questionnaire (DUX25), containing 4 subdomains (Physical, Home, Social, and Emotional) and a PWS-specific questionnaire (DUXPW). Results: At baseline, PWS children rated HRQOL similar to or higher than healthy and obese children. GH-treated children reported an increase in HRQOL in the Physical and Social subdomains and the DUXPW compared to untreated children. Parents reported an increase in the Physical and Emotional subdomains and borderline in the total DUX25 compared to parents of untreated children. During the 11 years of GH treatment, the Physical subdomain continued to improve, according to parents, whereas the Home, Social and Emotional subdomains, the total DUX25, and the DUXPW remained similar, according to children and parents. Conclusions: PWS children rated HRQOL equally to or better than healthy and obese children. HRQOL increased during GH treatment, in contrast to HRQOL of untreated children. This effect was sustained during long-term GH treatment. PWS children consider themselves quite happy, despite some difficulties related to the syndrome.
Growth hormone (GH) treatment is beneficial for children with Prader-Willi syndrome (PWS), but data about health-related quality of life (HRQOL) and effects of GH treatment are scarce. We, therefore, investigated the effects of GH treatment on HRQOL in PWS children. In a randomized controlled GH trial including 26 PWS children and during an 11-year longitudinal GH study in 76 children, we annually assessed HRQOL recorded by patients and parents, using a generic questionnaire (DUX25), containing 4 subdomains (Physical, Home, Social, and Emotional) and a PWS-specific questionnaire (DUXPW). At baseline, PWS children rated HRQOL similar to or higher than healthy and obese children. GH-treated children reported an increase in HRQOL in the Physical and Social subdomains and the DUXPW compared to untreated children. Parents reported an increase in the Physical and Emotional subdomains and borderline in the total DUX25 compared to parents of untreated children. During the 11 years of GH treatment, the Physical subdomain continued to improve, according to parents, whereas the Home, Social and Emotional subdomains, the total DUX25, and the DUXPW remained similar, according to children and parents. PWS children rated HRQOL equally to or better than healthy and obese children. HRQOL increased during GH treatment, in contrast to HRQOL of untreated children. This effect was sustained during long-term GH treatment. PWS children consider themselves quite happy, despite some difficulties related to the syndrome.
Growth hormone (GH) treatment is beneficial for children with Prader-Willi syndrome (PWS), but data about health-related quality of life (HRQOL) and effects of GH treatment are scarce. We, therefore, investigated the effects of GH treatment on HRQOL in PWS children.BACKGROUND/AIMSGrowth hormone (GH) treatment is beneficial for children with Prader-Willi syndrome (PWS), but data about health-related quality of life (HRQOL) and effects of GH treatment are scarce. We, therefore, investigated the effects of GH treatment on HRQOL in PWS children.In a randomized controlled GH trial including 26 PWS children and during an 11-year longitudinal GH study in 76 children, we annually assessed HRQOL recorded by patients and parents, using a generic questionnaire (DUX25), containing 4 subdomains (Physical, Home, Social, and Emotional) and a PWS-specific questionnaire (DUXPW).METHODSIn a randomized controlled GH trial including 26 PWS children and during an 11-year longitudinal GH study in 76 children, we annually assessed HRQOL recorded by patients and parents, using a generic questionnaire (DUX25), containing 4 subdomains (Physical, Home, Social, and Emotional) and a PWS-specific questionnaire (DUXPW).At baseline, PWS children rated HRQOL similar to or higher than healthy and obese children. GH-treated children reported an increase in HRQOL in the Physical and Social subdomains and the DUXPW compared to untreated children. Parents reported an increase in the Physical and Emotional subdomains and borderline in the total DUX25 compared to parents of untreated children. During the 11 years of GH treatment, the Physical subdomain continued to improve, according to parents, whereas the Home, Social and Emotional subdomains, the total DUX25, and the DUXPW remained similar, according to children and parents.RESULTSAt baseline, PWS children rated HRQOL similar to or higher than healthy and obese children. GH-treated children reported an increase in HRQOL in the Physical and Social subdomains and the DUXPW compared to untreated children. Parents reported an increase in the Physical and Emotional subdomains and borderline in the total DUX25 compared to parents of untreated children. During the 11 years of GH treatment, the Physical subdomain continued to improve, according to parents, whereas the Home, Social and Emotional subdomains, the total DUX25, and the DUXPW remained similar, according to children and parents.PWS children rated HRQOL equally to or better than healthy and obese children. HRQOL increased during GH treatment, in contrast to HRQOL of untreated children. This effect was sustained during long-term GH treatment. PWS children consider themselves quite happy, despite some difficulties related to the syndrome.CONCLUSIONSPWS children rated HRQOL equally to or better than healthy and obese children. HRQOL increased during GH treatment, in contrast to HRQOL of untreated children. This effect was sustained during long-term GH treatment. PWS children consider themselves quite happy, despite some difficulties related to the syndrome.
Author Hokken-Koelega, Anita C.S.
van Rijn, Marjon
Siemensma, Elbrich P.C.
Festen, Dederieke A.M.
Bakker, Nienke E.
Author_xml – sequence: 1
  givenname: Nienke E.
  surname: Bakker
  fullname: Bakker, Nienke E.
  email: n.bakker@kindengroei.nl
– sequence: 2
  givenname: Elbrich P.C.
  surname: Siemensma
  fullname: Siemensma, Elbrich P.C.
– sequence: 3
  givenname: Marjon
  surname: van Rijn
  fullname: van Rijn, Marjon
– sequence: 4
  givenname: Dederieke A.M.
  surname: Festen
  fullname: Festen, Dederieke A.M.
– sequence: 5
  givenname: Anita C.S.
  surname: Hokken-Koelega
  fullname: Hokken-Koelega, Anita C.S.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26279206$$D View this record in MEDLINE/PubMed
BookMark eNptkc1uEzEUhS1UREvpgj1CXsJiqH_GnjG7ErUNUiSgDWI5cjzXjcFjtx6PqvSZeEgcJWSBWPnI5zvH1r0v0VGIARB6TckHSoU6J4TUvKE1fYZOqJS8Yi2TRwdN22N0No4_C0Z42yjavEDHTLJGMSJP0O9PEMA647THl9aCyThafJ3iY17jeUxDeQwvE-g8QChewHPQPq-rG_A6Q4-_Tdq7vNmmFs4CdgHP1s73CQJ-dKXka9I9pOqH897h203oUxzgI77ANzr0cXBPpWQWQ07R-yKXafuVYuFFDHcuT70L5eK2iM0r9NxqP8LZ_jxF368ul7N5tfhy_Xl2sagMb2Suas0bZpmwsjaitqteCkYYtIIKY5QUalW3iiuutbRyJQnnBLQA1rbaUG4FP0Xvdr33KT5MMOZucKMB73WAOI0dbTinSjLVFvTtHp1WA_TdfXKDTpvu74QL8H4HmBTHMYE9IJR02wV2hwUW9vwf1riss9tORzv_38SbXeKXTneQDt17-w9s4qWN
CitedBy_id crossref_primary_10_1136_bmjopen_2019_036502
crossref_primary_10_1007_s00112_023_01856_x
crossref_primary_10_1186_s13023_023_02615_7
crossref_primary_10_3390_jcm10143176
crossref_primary_10_1186_s13023_025_03787_0
crossref_primary_10_1016_j_omtm_2019_03_001
crossref_primary_10_1159_000506943
crossref_primary_10_1111_jcpp_12601
crossref_primary_10_3390_diagnostics11050798
crossref_primary_10_1016_j_npep_2020_102084
crossref_primary_10_1007_s12519_022_00653_y
crossref_primary_10_1016_j_jnn_2021_12_005
crossref_primary_10_1136_bmjpo_2019_000630
crossref_primary_10_1007_s00431_023_05327_z
crossref_primary_10_1186_s13023_020_01527_0
crossref_primary_10_3390_ijms251810169
crossref_primary_10_1007_s12020_020_02547_3
crossref_primary_10_1111_jpc_14546
crossref_primary_10_1016_j_beem_2016_11_003
crossref_primary_10_1186_s12887_024_05109_y
Cites_doi 10.1007/s11136-004-2575-z
10.1097/MPG.0b013e31815ef87d
10.1177/0163278709338554
10.1093/jpepsy/25.6.381
10.1046/j.1365-2788.2002.00343.x
10.1007/BF02310555
10.1002/ajmg.a.36615
10.1183/09031936.00140407
10.1023/A:1012253723272
10.1067/mpd.2001.111504
10.1002/ajmg.1320600612
10.1136/adc.82.2.107
10.1007/s00787-014-0662-4
10.1159/000337218
10.1016/j.ridd.2013.05.024
10.1186/1477-7525-3-70
10.1038/sj.ejhg.5201135
10.1210/jc.2013-2012
10.1080/1536710X.2014.912184
10.3310/hta5040
10.1136/jmg.34.11.917
10.1111/j.1469-8749.2008.02039.x
10.1210/jc.2012-1182
10.1016/S0140-6736(02)07340-3
10.1023/A:1008801802877
10.1111/j.1440-1754.2007.01200.x
10.1159/000088792
10.1111/j.1365-2788.2006.00878.x
10.1007/s00520-008-0544-8
10.1002/pbc.20408
10.1203/00006450-200003000-00006
10.1002/ajmg.a.36845
10.1007/s10803-004-2551-z
10.1002/ajmg.a.36634
10.1111/j.1651-2227.2010.01904.x
10.1023/A:1008848218806
10.1002/pbc.22078
ContentType Journal Article
Copyright 2015 S. Karger AG, Basel
2015 S. Karger AG, Basel.
Copyright_xml – notice: 2015 S. Karger AG, Basel
– notice: 2015 S. Karger AG, Basel.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1159/000437141
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1663-2826
EndPage 239
ExternalDocumentID 26279206
10_1159_000437141
437141
Genre Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
0~5
0~B
30W
327
3O.
3V.
4.4
53G
7RV
7X7
88E
8AO
8FI
8FJ
AAYIC
ABJNI
ABPAZ
ABUWG
ACGFS
ACPRK
ACPSR
ADBBV
AENEX
AEYAO
AFJJK
AFKRA
AFRAH
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZPMC
AZQEC
BENPR
BKEYQ
BKNYI
BPHCQ
BVXVI
CAG
CCPQU
COF
CYUIP
DU5
E0A
EBS
EJD
EMOBN
EX3
F5P
FB.
FYUFA
HMCUK
HZ~
IY7
K9-
KUZGX
M0R
M1P
NAPCQ
O1H
O9-
OVD
PQQKQ
PROAC
PSQYO
RKO
RXVBD
SV3
TEORI
UJ6
UKHRP
WOW
AAYXX
ABBTS
ABWCG
AFFHD
AHFRZ
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
PUEGO
ID FETCH-LOGICAL-c376t-4a372f25f64c54fbd65202e8515cc9659b489393aa6f6b60330ea5e288ac13f53
ISICitedReferencesCount 23
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000364646500003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1663-2818
1663-2826
IngestDate Sun Aug 24 02:58:42 EDT 2025
Mon Jul 21 05:40:33 EDT 2025
Sat Nov 29 07:59:38 EST 2025
Tue Nov 18 20:47:38 EST 2025
Thu Aug 29 12:04:28 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Prader-Willi syndrome
Health-related quality of life
Growth hormone treatment
Language English
License Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
https://www.karger.com/Services/SiteLicenses
2015 S. Karger AG, Basel.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c376t-4a372f25f64c54fbd65202e8515cc9659b489393aa6f6b60330ea5e288ac13f53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 26279206
PQID 1733196298
PQPubID 23479
PageCount 9
ParticipantIDs crossref_primary_10_1159_000437141
proquest_miscellaneous_1733196298
crossref_citationtrail_10_1159_000437141
pubmed_primary_26279206
karger_primary_437141
PublicationCentury 2000
PublicationDate 2015-01-01
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – month: 01
  year: 2015
  text: 2015-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
PublicationTitle Hormone research in paediatrics
PublicationTitleAlternate Horm Res Paediatr
PublicationYear 2015
References Vogels A, Van Den Ende J, Keymolen K, Mortier G, Devriendt K, Legius E, Fryns JP: Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders. Eur J Hum Genet 2004;12:238-240.1467939710.1038/sj.ejhg.5201135
Bertella L, Mori I, Grugni G, Pignatti R, Ceriani F, Molinari E, Ceccarelli A, Sartorio A, Vettor R, Semenza C: Quality of life and psychological well-being in GH-treated, adult PWS patients: a longitudinal study. J Intellect Disabil Res 2007;51:302-311.1732681110.1111/j.1365-2788.2006.00878.x
Flapper BC, Duiverman EJ, Gerritsen J, Postema K, van der Schans CP: Happiness to be gained in paediatric asthma care. Eur Respir J 2008;32:1555-1562.1861455810.1183/09031936.00140407
Hensel E, Rose J, Kroese BS, Banks-Smith J: Subjective judgements of quality of life: a comparison study between people with intellectual disability and those without disability. J Intellect Disabil Res 2002;46:95-107.1186938010.1046/j.1365-2788.2002.00343.x
Vrijmoet-Wiersma CM, Kolk AM, Grootenhuis MA, Spek EM, van Klink JM, Egeler RM, Bredius RG, Koopman HM: Child and parental adaptation to pediatric stem cell transplantation. Support Care Cancer 2009;17:707-714.1905093910.1007/s00520-008-0544-8
Koopman HM: Reference Values DUX 25 - A Health-Related Quality of Life Instrument for Children. Leiden, LUMC, 2008.
Lo ST, Siemensma EP, Festen DA, Collin PJ, Hokken-Koelega AC: Behavior in children with Prader-Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal study. Eur Child Adolesc Psychiatry 2014, Epub ahead of print.2552284010.1007/s00787-014-0662-4
Eiser C, Morse R: Quality-of-life measures in chronic diseases of childhood. Health Technol Assess 2001;5:1-157.1126242110.3310/hta5040
Baars RM, Atherton CI, Koopman HM, Bullinger M, Power M; DISABKIDS group: The European DISABKIDS project: development of seven condition-specific modules to measure health related quality of life in children and adolescents. Health Qual Life Outcomes 2005;3:70.1628394710.1186/1477-7525-3-70
Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP, Wit JM: Continuing positive secular growth change in the Netherlands 1955-1997. Pediatr Res 2000;47:316-323.1070972910.1203/00006450-200003000-00006
Bekkering WP, Vlieland TP, Koopman HM, Schaap GR, Schreuder HW, Beishuizen A, Tissing WJ, Hoogerbrugge PM, Anninga JK, Taminiau AH: The Bt-DUX: development of a subjective measure of health-related quality of life in patients who underwent surgery for lower extremity malignant bone tumor. Pediatr Blood Cancer 2009;53:348-355.1945920010.1002/pbc.22078
Bannink EM, van Pareren YK, Theunissen NC, Raat H, Mulder PG, Hokken-Koelega AC: Quality of life in adolescents born small for gestational age: does growth hormone make a difference? Horm Res 2005;64:166-174.1620509510.1159/000088792
Dykens EM, Cassidy SB: Correlates of maladaptive behavior in children and adults with Prader-Willi syndrome. Am J Med Genet 1995;60:546-549.882589310.1002/ajmg.1320600612
Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F: Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993;91:398-402.8424017
Cassidy SB: Prader-Willi syndrome. J Med Genet 1997;34:917-923.939188610.1136/jmg.34.11.917
van Doorn RK, Winkler LM, Zwinderman KH, Mearin ML, Koopman HM: CDDUX: a disease-specific health-related quality-of-life questionnaire for children with celiac disease. J Pediatr Gastroenterol Nutr 2008;47:147-152.1866486510.1097/MPG.0b013e31815ef87d
Lo ST, Siemensma E, Collin P, Hokken-Koelega A: Impaired theory of mind and symptoms of autism spectrum disorder in children with Prader-Willi syndrome. Res Dev Disabil 2013;34:2764-2773.2379237310.1016/j.ridd.2013.05.024
Eiser C, Morse R: Can parents rate their child's health-related quality of life? Results of a systematic review. Qual Life Res 2001;10:347-357.1176324710.1023/A:1012253723272
Sipila I, Sintonen H, Hietanen H, Apajasalo M, Alanne S, Viita AM, Leinonen E: Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome. Acta Paediatr 2010;99:1712-1718.2054593210.1111/j.1651-2227.2010.01904.x
Koenig K, Klin A, Schultz R: Deficits in social attribution ability in Prader-Willi syndrome. J Autism Dev Disord 2004;34:573-582.1562861010.1007/s10803-004-2551-z
Koopman HM, Theunissen NCM, Vogels AGC, Kamphuis RP, Verrips GH: The DUX-25, a short form questionnaire for measuring health related quality of life of children with chronic illness. Qual Life Res 1998;7:619.
West BT: Analyzing longitudinal data with the linear mixed models procedure in SPSS. Eval Health Prof 2009;32:207-228.1967963410.1177/0163278709338554
Kolsteren MM, Koopman HM, Schalekamp G, Mearin ML: Health-related quality of life in children with celiac disease. J Pediatr 2001;138:593-595.1129572910.1067/mpd.2001.111504
Flapper BC, Schoemaker MM: Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD. Dev Med Child Neurol 2008;50:294-299.1835299710.1111/j.1469-8749.2008.02039.x
Lem AJ, Jobse I, van der Kaay DC, de Ridder MA, Raat H, Hokken-Koelega AC: Health-related quality of life in short children born small for gestational age: effects of growth hormone treatment and postponement of puberty. Horm Res Paediatr 2012;77:170-179.2244114010.1159/000337218
Theunissen NC, Vogels TG, Koopman HM, Verrips GH, Zwinderman KA, Verloove-Vanhorick SP, Wit JM: The proxy problem: child report versus parent report in health-related quality of life research. Qual Life Res 1998;7:387-397.969171910.1023/A:1008801802877
Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, et al: Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. J Clin Endocrinol Metab 2012;97:2307-2314.2250870710.1210/jc.2012-1182
Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D: Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet 2002;359:135-136.1180926010.1016/S0140-6736(02)07340-3
Bakker NE, Kuppens RJ, Siemensma EP, et al: Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects. J Clin Endocrinol Metab 2013;98:4013-4022.2400175010.1210/jc.2013-2012
Cronbach LJ: Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.10.1007/BF02310555
Petersen C, Schmidt S, Power M, Bullinger M; DISABKIDS Group: Development and pilot-testing of a health-related quality of life chronic generic module for children and adolescents with chronic health conditions: a European perspective. Qual Life Res 2005;14:1065-1077.1604190210.1007/s11136-004-2575-z
Waters E, Salmon L, Wake M: The parent-form child health questionnaire in Australia: comparison of reliability, validity, structure, and norms. J Pediatr Psychol 2000;25:381-391.1098004310.1093/jpepsy/25.6.381
Chaij C, Han M, Graziano L: Latino families with a child with Prader-Willi syndrome: exploring needs for support. J Soc Work Disabil Rehabil 2014;13:207-225.2481168310.1080/1536710X.2014.912184
Fredriks AM, van Buuren S, Wit JM, Verloove-Vanhorick SP: Body index measurements in 1996-7 compared with 1980. Arch Dis Child 2000;82:107-112.1064836210.1136/adc.82.2.107
Ogata H, Ihara H, Murakami N, Gito M, Kido Y, Nagai T: Autism spectrum disorders and hyperactive/impulsive behaviors in Japanese patients with Prader-Willi syndrome: a comparison between maternal uniparental disomy and deletion cases. Am J Med Genet Part A 2014;164A:2180-2186.2485075210.1002/ajmg.a.36615
Vogels T, Verrips GH, Verloove-Vanhorick SP, Fekkes M, Kamphuis RP, Koopman HM, Theunissen NC, Wit JM: Measuring health-related quality of life in children: the development of the TACQOL parent form. Qual Life Res 1998;7:457-465.969172510.1023/A:1008848218806
Caliandro P, Grugni G, Padua L, Kodra Y, Tonali P, Gargantini L, Ragusa L, Crino A, Taruscio D: Quality of life assessment in a sample of patients affected by Prader-Willi syndrome. J Paediatr Child Health 2007;43:826-830.1780366810.1111/j.1440-1754.2007.01200.x
Koopman HM, Koetsier JA, Taminiau AH, Hijnen KE, Bresters D, Egeler RM: Health-related quality of life and coping strategies of children after treatment of a malignant bone tumor: a 5-year follow-up study. Pediatr Blood Cancer 2005;45:694-699.1592435910.1002/pbc.20408
Ihara H, Ogata H, Sayama M, Kato A, Gito M, Murakami N, Kido Y, Nagai T: QOL in caregivers of Japanese patients with Prader-Willi syndrome with reference to age and genotype. Am J Med Genet A 2014;164A:2226-2231.2495302610.1002/ajmg.a.36634
Lionti T, Reid SM, White SM, Rowell MM: A population-based profile of 160 Australians with Prader-Willi syndrome: trends in diagnosis, birth prevalence and birth characteristics. Am J Med Genet A 2015;167A:371-378.2542439610.1002/ajmg.a.36845
ref13
ref35
ref12
ref34
ref15
ref37
ref14
ref36
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – reference: Flapper BC, Duiverman EJ, Gerritsen J, Postema K, van der Schans CP: Happiness to be gained in paediatric asthma care. Eur Respir J 2008;32:1555-1562.1861455810.1183/09031936.00140407
– reference: Caliandro P, Grugni G, Padua L, Kodra Y, Tonali P, Gargantini L, Ragusa L, Crino A, Taruscio D: Quality of life assessment in a sample of patients affected by Prader-Willi syndrome. J Paediatr Child Health 2007;43:826-830.1780366810.1111/j.1440-1754.2007.01200.x
– reference: Lo ST, Siemensma E, Collin P, Hokken-Koelega A: Impaired theory of mind and symptoms of autism spectrum disorder in children with Prader-Willi syndrome. Res Dev Disabil 2013;34:2764-2773.2379237310.1016/j.ridd.2013.05.024
– reference: Theunissen NC, Vogels TG, Koopman HM, Verrips GH, Zwinderman KA, Verloove-Vanhorick SP, Wit JM: The proxy problem: child report versus parent report in health-related quality of life research. Qual Life Res 1998;7:387-397.969171910.1023/A:1008801802877
– reference: Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F: Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993;91:398-402.8424017
– reference: Waters E, Salmon L, Wake M: The parent-form child health questionnaire in Australia: comparison of reliability, validity, structure, and norms. J Pediatr Psychol 2000;25:381-391.1098004310.1093/jpepsy/25.6.381
– reference: van Doorn RK, Winkler LM, Zwinderman KH, Mearin ML, Koopman HM: CDDUX: a disease-specific health-related quality-of-life questionnaire for children with celiac disease. J Pediatr Gastroenterol Nutr 2008;47:147-152.1866486510.1097/MPG.0b013e31815ef87d
– reference: Lo ST, Siemensma EP, Festen DA, Collin PJ, Hokken-Koelega AC: Behavior in children with Prader-Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal study. Eur Child Adolesc Psychiatry 2014, Epub ahead of print.2552284010.1007/s00787-014-0662-4
– reference: Flapper BC, Schoemaker MM: Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD. Dev Med Child Neurol 2008;50:294-299.1835299710.1111/j.1469-8749.2008.02039.x
– reference: Eiser C, Morse R: Can parents rate their child's health-related quality of life? Results of a systematic review. Qual Life Res 2001;10:347-357.1176324710.1023/A:1012253723272
– reference: Ogata H, Ihara H, Murakami N, Gito M, Kido Y, Nagai T: Autism spectrum disorders and hyperactive/impulsive behaviors in Japanese patients with Prader-Willi syndrome: a comparison between maternal uniparental disomy and deletion cases. Am J Med Genet Part A 2014;164A:2180-2186.2485075210.1002/ajmg.a.36615
– reference: West BT: Analyzing longitudinal data with the linear mixed models procedure in SPSS. Eval Health Prof 2009;32:207-228.1967963410.1177/0163278709338554
– reference: Koopman HM: Reference Values DUX 25 - A Health-Related Quality of Life Instrument for Children. Leiden, LUMC, 2008.
– reference: Koopman HM, Koetsier JA, Taminiau AH, Hijnen KE, Bresters D, Egeler RM: Health-related quality of life and coping strategies of children after treatment of a malignant bone tumor: a 5-year follow-up study. Pediatr Blood Cancer 2005;45:694-699.1592435910.1002/pbc.20408
– reference: Vrijmoet-Wiersma CM, Kolk AM, Grootenhuis MA, Spek EM, van Klink JM, Egeler RM, Bredius RG, Koopman HM: Child and parental adaptation to pediatric stem cell transplantation. Support Care Cancer 2009;17:707-714.1905093910.1007/s00520-008-0544-8
– reference: Cronbach LJ: Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.10.1007/BF02310555
– reference: Eiser C, Morse R: Quality-of-life measures in chronic diseases of childhood. Health Technol Assess 2001;5:1-157.1126242110.3310/hta5040
– reference: Bakker NE, Kuppens RJ, Siemensma EP, et al: Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects. J Clin Endocrinol Metab 2013;98:4013-4022.2400175010.1210/jc.2013-2012
– reference: Bekkering WP, Vlieland TP, Koopman HM, Schaap GR, Schreuder HW, Beishuizen A, Tissing WJ, Hoogerbrugge PM, Anninga JK, Taminiau AH: The Bt-DUX: development of a subjective measure of health-related quality of life in patients who underwent surgery for lower extremity malignant bone tumor. Pediatr Blood Cancer 2009;53:348-355.1945920010.1002/pbc.22078
– reference: Baars RM, Atherton CI, Koopman HM, Bullinger M, Power M; DISABKIDS group: The European DISABKIDS project: development of seven condition-specific modules to measure health related quality of life in children and adolescents. Health Qual Life Outcomes 2005;3:70.1628394710.1186/1477-7525-3-70
– reference: Hensel E, Rose J, Kroese BS, Banks-Smith J: Subjective judgements of quality of life: a comparison study between people with intellectual disability and those without disability. J Intellect Disabil Res 2002;46:95-107.1186938010.1046/j.1365-2788.2002.00343.x
– reference: Cassidy SB: Prader-Willi syndrome. J Med Genet 1997;34:917-923.939188610.1136/jmg.34.11.917
– reference: Sipila I, Sintonen H, Hietanen H, Apajasalo M, Alanne S, Viita AM, Leinonen E: Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome. Acta Paediatr 2010;99:1712-1718.2054593210.1111/j.1651-2227.2010.01904.x
– reference: Dykens EM, Cassidy SB: Correlates of maladaptive behavior in children and adults with Prader-Willi syndrome. Am J Med Genet 1995;60:546-549.882589310.1002/ajmg.1320600612
– reference: Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D: Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet 2002;359:135-136.1180926010.1016/S0140-6736(02)07340-3
– reference: Lem AJ, Jobse I, van der Kaay DC, de Ridder MA, Raat H, Hokken-Koelega AC: Health-related quality of life in short children born small for gestational age: effects of growth hormone treatment and postponement of puberty. Horm Res Paediatr 2012;77:170-179.2244114010.1159/000337218
– reference: Ihara H, Ogata H, Sayama M, Kato A, Gito M, Murakami N, Kido Y, Nagai T: QOL in caregivers of Japanese patients with Prader-Willi syndrome with reference to age and genotype. Am J Med Genet A 2014;164A:2226-2231.2495302610.1002/ajmg.a.36634
– reference: Fredriks AM, van Buuren S, Wit JM, Verloove-Vanhorick SP: Body index measurements in 1996-7 compared with 1980. Arch Dis Child 2000;82:107-112.1064836210.1136/adc.82.2.107
– reference: Koopman HM, Theunissen NCM, Vogels AGC, Kamphuis RP, Verrips GH: The DUX-25, a short form questionnaire for measuring health related quality of life of children with chronic illness. Qual Life Res 1998;7:619.
– reference: Kolsteren MM, Koopman HM, Schalekamp G, Mearin ML: Health-related quality of life in children with celiac disease. J Pediatr 2001;138:593-595.1129572910.1067/mpd.2001.111504
– reference: Koenig K, Klin A, Schultz R: Deficits in social attribution ability in Prader-Willi syndrome. J Autism Dev Disord 2004;34:573-582.1562861010.1007/s10803-004-2551-z
– reference: Chaij C, Han M, Graziano L: Latino families with a child with Prader-Willi syndrome: exploring needs for support. J Soc Work Disabil Rehabil 2014;13:207-225.2481168310.1080/1536710X.2014.912184
– reference: Vogels T, Verrips GH, Verloove-Vanhorick SP, Fekkes M, Kamphuis RP, Koopman HM, Theunissen NC, Wit JM: Measuring health-related quality of life in children: the development of the TACQOL parent form. Qual Life Res 1998;7:457-465.969172510.1023/A:1008848218806
– reference: Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP, Wit JM: Continuing positive secular growth change in the Netherlands 1955-1997. Pediatr Res 2000;47:316-323.1070972910.1203/00006450-200003000-00006
– reference: Petersen C, Schmidt S, Power M, Bullinger M; DISABKIDS Group: Development and pilot-testing of a health-related quality of life chronic generic module for children and adolescents with chronic health conditions: a European perspective. Qual Life Res 2005;14:1065-1077.1604190210.1007/s11136-004-2575-z
– reference: Lionti T, Reid SM, White SM, Rowell MM: A population-based profile of 160 Australians with Prader-Willi syndrome: trends in diagnosis, birth prevalence and birth characteristics. Am J Med Genet A 2015;167A:371-378.2542439610.1002/ajmg.a.36845
– reference: Vogels A, Van Den Ende J, Keymolen K, Mortier G, Devriendt K, Legius E, Fryns JP: Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders. Eur J Hum Genet 2004;12:238-240.1467939710.1038/sj.ejhg.5201135
– reference: Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, et al: Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. J Clin Endocrinol Metab 2012;97:2307-2314.2250870710.1210/jc.2012-1182
– reference: Bertella L, Mori I, Grugni G, Pignatti R, Ceriani F, Molinari E, Ceccarelli A, Sartorio A, Vettor R, Semenza C: Quality of life and psychological well-being in GH-treated, adult PWS patients: a longitudinal study. J Intellect Disabil Res 2007;51:302-311.1732681110.1111/j.1365-2788.2006.00878.x
– reference: Bannink EM, van Pareren YK, Theunissen NC, Raat H, Mulder PG, Hokken-Koelega AC: Quality of life in adolescents born small for gestational age: does growth hormone make a difference? Horm Res 2005;64:166-174.1620509510.1159/000088792
– ident: ref9
  doi: 10.1007/s11136-004-2575-z
– ident: ref20
  doi: 10.1097/MPG.0b013e31815ef87d
– ident: ref25
  doi: 10.1177/0163278709338554
– ident: ref29
  doi: 10.1093/jpepsy/25.6.381
– ident: ref31
  doi: 10.1046/j.1365-2788.2002.00343.x
– ident: ref24
  doi: 10.1007/BF02310555
– ident: ref37
  doi: 10.1002/ajmg.a.36615
– ident: ref17
  doi: 10.1183/09031936.00140407
– ident: ref13
  doi: 10.1023/A:1012253723272
– ident: ref14
  doi: 10.1067/mpd.2001.111504
– ident: ref26
  doi: 10.1002/ajmg.1320600612
– ident: ref23
  doi: 10.1136/adc.82.2.107
– ident: ref34
  doi: 10.1007/s00787-014-0662-4
– ident: ref27
  doi: 10.1159/000337218
– ident: ref32
  doi: 10.1016/j.ridd.2013.05.024
– ident: ref18
  doi: 10.1186/1477-7525-3-70
– ident: ref2
  doi: 10.1038/sj.ejhg.5201135
– ident: ref4
  doi: 10.1210/jc.2013-2012
– ident: ref30
  doi: 10.1080/1536710X.2014.912184
– ident: ref10
  doi: 10.3310/hta5040
– ident: ref3
  doi: 10.1136/jmg.34.11.917
– ident: ref16
  doi: 10.1111/j.1469-8749.2008.02039.x
– ident: ref5
  doi: 10.1210/jc.2012-1182
– ident: ref36
  doi: 10.1016/S0140-6736(02)07340-3
– ident: ref11
  doi: 10.1023/A:1008801802877
– ident: ref7
  doi: 10.1111/j.1440-1754.2007.01200.x
– ident: ref28
  doi: 10.1159/000088792
– ident: ref6
  doi: 10.1111/j.1365-2788.2006.00878.x
– ident: ref15
  doi: 10.1007/s00520-008-0544-8
– ident: ref19
  doi: 10.1002/pbc.20408
– ident: ref22
  doi: 10.1203/00006450-200003000-00006
– ident: ref1
  doi: 10.1002/ajmg.a.36845
– ident: ref33
  doi: 10.1007/s10803-004-2551-z
– ident: ref35
  doi: 10.1002/ajmg.a.36634
– ident: ref8
  doi: 10.1111/j.1651-2227.2010.01904.x
– ident: ref12
  doi: 10.1023/A:1008848218806
– ident: ref21
  doi: 10.1002/pbc.22078
SSID ssj0000387917
Score 2.2225764
Snippet Background/Aims: Growth hormone (GH) treatment is beneficial for children with Prader-Willi syndrome (PWS), but data about health-related quality of life...
Growth hormone (GH) treatment is beneficial for children with Prader-Willi syndrome (PWS), but data about health-related quality of life (HRQOL) and effects of...
SourceID proquest
pubmed
crossref
karger
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 231
SubjectTerms Adolescent
Body Composition - drug effects
Child
Female
Health Status
Hormone Replacement Therapy
Human Growth Hormone - pharmacology
Human Growth Hormone - therapeutic use
Humans
Longitudinal Studies
Male
Original Paper
Prader-Willi Syndrome - drug therapy
Prader-Willi Syndrome - psychology
Quality of Life
Surveys and Questionnaires
Treatment Outcome
Title Beneficial Effect of Growth Hormone Treatment on Health-Related Quality of Life in Children with Prader-Willi Syndrome: A Randomized Controlled Trial and Longitudinal Study
URI https://karger.com/doi/10.1159/000437141
https://www.ncbi.nlm.nih.gov/pubmed/26279206
https://www.proquest.com/docview/1733196298
Volume 84
WOSCitedRecordID wos000364646500003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1663-2826
  dateEnd: 20151231
  omitProxy: false
  ssIdentifier: ssj0000387917
  issn: 1663-2818
  databaseCode: BENPR
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Consumer Health Database
  customDbUrl:
  eissn: 1663-2826
  dateEnd: 20151231
  omitProxy: false
  ssIdentifier: ssj0000387917
  issn: 1663-2818
  databaseCode: M0R
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/familyhealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection
  customDbUrl:
  eissn: 1663-2826
  dateEnd: 20151231
  omitProxy: false
  ssIdentifier: ssj0000387917
  issn: 1663-2818
  databaseCode: 7X7
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Nursing & Allied Health Database
  customDbUrl:
  eissn: 1663-2826
  dateEnd: 20151231
  omitProxy: false
  ssIdentifier: ssj0000387917
  issn: 1663-2818
  databaseCode: 7RV
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6ljwMXBLTQ8IgWhCqkysKxvX5wS6uEHkKokhTlZq3XtnCT2CGPqvCb-GH8DGZ213YqilQOXFbWZjd2NF9mZ8Yz3xDy1mVctGMHS5QZNxxXCIObLDaspM1dDhZ8ZEWy2YQ3GPiTSXDRaPwqa2GuZ16e-zc3weK_ihrmQNhYOvsP4q6-FCbgGoQOI4gdxnsJ_hS0l6aF0NTEYA9-BG97_fXkHCzUAszKcZVeXuS6EsmQaXFgfipWDfnivZ-lklPkbLviGymO4mSpMm1PRprxQFW4D3keF_PsB4aNVQ78DC7HsjMIRuj7BbZH2sSyFdeoYrbVxnH5dJqASMZiFrzsJVLH8_lUp4IMQC9Nk7qYYpRhsHM15yphLYJd8Lh1IBhrtYbZVa6LlK7qFIQehn21Ao6R-xm-tqMjxTom0mZbMRGlxsGOMsCZ1CTbd8xp3a_a02mMO9uKXJ1Nfx4wLFAZmQ5SHbbrU7TMHBh8DnuX_X447k7Gx4tvBvY3wzwA3exlh-xZHgtQ_34yh1U0EJMIAtkeunpMTYMFN3xf3e6W8bQ_xVqB5d9dI2kijR-Rh9q3oR2FycekkeRPyEEn5-ti_p0eU5ltLF_jHJCfNUypgiktUqpgSjUQaAVTWuT0NkyphinuQpjSLKclTCnClG7DlJYw_UA7tAYprUFKJUgpfES3QUolSA_JZa87Pjs3dOcQQ8CBuTYcbntWarHUdQRz0ih2mWVaCXgXTAik0IyQcymwOXdTN3JN2zYTzhLL90Fz2Smzn5LdHH7nEaG-8DBrAgxrjq66HYkU1nLLSyKWmiJuknelSEKhafWxu8sslO41C8JKek3yplq6UFwydy06VHKtlpTzr0sxh3AC4Gs9nifFZhW2se1q4FqB3yTPlPyrvZaLBKGm-_weu1-QB_V_6SXZXS83ySuyL67X2WrZIjve8AuOE0-OfovsnXYHF8OWRPJv9r_iyQ
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Beneficial+Effect+of+Growth+Hormone+Treatment+on+Health-Related+Quality+of+Life+in+Children+with+Prader-Willi+Syndrome%3A+A+Randomized+Controlled+Trial+and+Longitudinal+Study&rft.jtitle=Hormone+research+in+paediatrics&rft.au=Bakker%2C+Nienke+E&rft.au=Siemensma%2C+Elbrich+P+C&rft.au=van+Rijn%2C+Marjon&rft.au=Festen%2C+Dederieke+A+M&rft.date=2015-01-01&rft.issn=1663-2826&rft.eissn=1663-2826&rft.volume=84&rft.issue=4&rft.spage=231&rft_id=info:doi/10.1159%2F000437141&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-2818&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-2818&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-2818&client=summon